The 20 Best Cerebral Hypoxia Doctors in Massachusetts, US

Ryan Chua is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Leominster, Massachusetts. Dr. Chua has been practicing medicine for over 23 years and is rated as a Distinguished provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Tracheoesophageal Fistula, Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Gastrostomy, and Endoscopy.

Plutarco Castellanos is an Intensive Care Medicine specialist and a Sleep Medicine provider in Leominster, Massachusetts. Dr. Castellanos has been practicing medicine for over 29 years and is rated as a Distinguished provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Pneumonia, Gastrostomy, and Advanced Bronchoscopy.

Mandeep Hundal is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Leominster, Massachusetts. Dr. Hundal has been practicing medicine for over 24 years and is rated as a Distinguished provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Pneumonia, Lung Nodules, and Gastrostomy.

Sally Vitali is a Pediatrics provider in Boston, Massachusetts. Dr. Vitali is rated as a Distinguished provider by MediFind in the treatment of Cerebral Hypoxia. Her top areas of expertise are Cerebral Hypoxia, Pulmonary Hypertension, High Blood Pressure in Infants, Spontaneous Coronary Artery Dissection (SCAD), and Gastrostomy.

Payam Aghassi is an Intensive Care Medicine specialist and a Sleep Medicine provider in Leominster, Massachusetts. Dr. Aghassi has been practicing medicine for over 30 years and is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Obstructive Sleep Apnea, Gastrostomy, and Endoscopy.

Corey Saltin is an Intensive Care Medicine provider in Marlborough, Massachusetts. Dr. Saltin is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Cerebral Hypoxia, Pneumonia, and Advanced Bronchoscopy.

Elisabeth Riviello is an Internal Medicine provider in Boston, Massachusetts. Dr. Riviello is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. Her top areas of expertise are Cerebral Hypoxia, Acute Respiratory Distress Syndrome (ARDS), Pneumonia, Severe Acute Respiratory Syndrome (SARS), and Gastrostomy.

Michael Fahey is a Pediatrics specialist and a Pediatric Cardiologist in Worcester, Massachusetts. Dr. Fahey has been practicing medicine for over 24 years and is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Niemann-Pick Disease, Lissencephaly 2, Agyria Pachygyria Polymicrogyria, Cerebral Hypoxia, and Rhizotomy.

Robert Thomas is an Internal Medicine provider in Boston, Massachusetts. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Central Sleep Apnea, Obstructive Sleep Apnea, Idiopathic Hypersomnia, and Irregular Sleep-Wake Syndrome.

Dr. Wertheim is a member of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital.  He specializes in the care of patients with pulmonary arterial hypertension (PAH) and complex heart-lung interactions.  After studying biochemistry at Lafayette College, Dr. Wertheim received his Doctorate in Medicine from Harvard Medical School in 2011.  At the Massachusetts General Hospital, he completed his residency in internal medicine in 2014.   Dr. Wertheim then trained in pulmonary and critical care medicine at Brigham and Women’s Hospital, and he graduated in 2017.  During this time, he was the first physician selected for the Burke Advanced Fellowship in Pulmonary Heart Disease, one of the few dedicated pulmonary hypertension training programs in the country.    His clinical interests include pulmonary hypertension, pulmonary embolism, critical care medicine, unexplained dyspnea, and cardiopulmonary exercise testing.  He founded the Rheumatic Pulmonary Vascular Disease Clinic to promptly diagnose pulmonary hypertension in patients with connective tissue diseases such as systemic sclerosis.  In 2021-2022, Dr. Wertheim’s patient satisfaction scores ranked in the top 10% of physician nationwide.  He is board-certified in pulmonary disease, critical care medicine, and internal medicine.  As a scientist, Dr. Wertheim studies the biology of pulmonary arterial hypertension to identify treatment strategies.  He earned research awards from the Pulmonary Vascular Research Institute and Brigham and Women’s Hospital/Hearst Foundation.  He receives funding from the National Heart Lung and Blood Institute/National Institutes of Health.  A list of his publications can be found here.A member of the Harvard Medical School faculty, Dr. Wertheim trains fellows and residents in his clinic and inpatient practice at Brigham and Women’s Hospital.  Outside of medicine, he enjoys time with his wife and daughters, saltwater fishing, boating, working with tools, and enjoying the outdoors. Dr. Wertheim is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Pulmonary Hypertension, Cerebral Hypoxia, Pulmonary Veno-Occlusive Disease, and Lung Metastases.

Kai Swenson is an Internal Medicine provider in Boston, Massachusetts. Dr. Swenson is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Pleural Effusion, Cerebral Hypoxia, Lymphofollicular Hyperplasia, Endoscopy, and Advanced Bronchoscopy.

Dr. Benjamin Raby is the director of the Pulmonary Genetics Center and a physician at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.He received his medical degree from McGill University Faculty of Medicine, and then completed a residency in internal medicine at Sir Mortimer B. Davis Jewish General Hospital. He then undertook fellowship programs in pulmonary disease at McGill University Health Centre, Montreal Genome Centre at McGill University (now the McGill University and Genome Quebec Innovation Centre) and BWH. He is board certified in internal medicine and pulmonary disease.Dr. Raby’s research focuses on identifying the genetic basis of lung diseases using genome-wide integrative approaches in human populations. He has worked on multiple asthma studies funded by the National Institutes of Health, including a study of structural genetic variation in childhood asthma and another that leveraged clinical, genomic and environmental data to investigate the molecular determinants of suboptimal asthma control. He is the author of more than 140 peer-reviewed publications, is a founding member of the EVE Asthma Consortium, and serves on the editorial boards of several allergy, asthma and genetics subspecialty journals. Dr. Raby is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Asthma, Sleeve Gastrectomy, and Lung Transplant.

Ioana Preston is an Intensive Care Medicine provider in Boston, Massachusetts. Dr. Preston is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. Her top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Heart Failure with Preserved Ejection Fraction (HFpEF), Cerebral Hypoxia, and Lung Transplant.

Dr. Edwin Kepner Silverman is chief of the Channing Division of Network Medicine and a physician at Brigham and Women’s Hospital (BWH). He is also a professor of medicine at Harvard Medical School.He received his medical degree from Washington University School of Medicine. He then completed a residency in internal medicine and a fellowship in pulmonary disease at BWH. He is board certified in critical care medicine and pulmonary medicine.Dr. Silverman’s clinical interests include alpha 1-antitrypsin deficiency, emphysema, pulmonary fibrosis and chronic obstructive pulmonary disease (COPD). He has served as a principal investigator of multiple COPD genetics studies funded by the National Institutes of Health, including the NETT Genetics Ancillary Study, the Transcontinental COPD Genetics Study, the Alpha-1 Antitrypsin Genetic Modifiers Study and the COPDGene Study. His research uses a variety of genetic analysis approaches to investigate the genetic influences of complex lung diseases, including integrative genomics, linkage analysis, familial aggregation analysis, rare variant analysis and epigenetic studies. He has authored over 320 peer-reviewed publications and is the recipient of the BWH Kenneth L. Baughman Faculty Mentoring Award. Dr. Silverman is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Bronchitis, Pulmonary Fibrosis, and Vulvectomy.

Ali Khodabandeh is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Concord, Massachusetts. Dr. Khodabandeh has been practicing medicine for over 28 years and is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Asthma in Children, Chronic Obstructive Pulmonary Disease (COPD), Asthma, Lung Metastases, and Pacemaker Implantation.

Dr. Spyropoulos is an Attending neonatologist in the Newborn Intensive Care Unit (NICU)and an Instructor in Pediatrics at Harvard Medical School. Dr. Spyropoulos performs basic and translational research in hemodynamics and cardiac metabolism as relates to cardiopulmonary diseases of prematurity. His research focuses on elucidating the mechanisms of cardiac metabolic dysregulation in heart failure and identifying novel therapies for prevention and treatment of this devastating disease. Dr. Spyropoulos is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are High Blood Pressure in Infants, Cerebral Hypoxia, Pulmonary Hypertension, and Premature Infant.

Dr. Quan is a Senior Physician in the Division of Sleep and Circadian Disorders at Brigham and Women’s Hospital and the Gerald E. McGinnis Professor of Sleep Medicine at Harvard Medical School. In addition, he is Professor Emeritus of Medicine at the University of Arizona where he was Chief of Pulmonary and Critical Care Medicine, Associate Head of the Department of Medicine, Program Director of the GCRC and Director of the Sleep Disorders Center. He also is an adjunct faculty member in the Arizona State University College of Nursing and Health Innovation. He is the Field Chief Editor of Frontiers in Sleep, was the founding editor of the Journal of Clinical Sleep Medicine, and has served as president of the American Academy of Sleep Medicine. His current research activities focus on the epidemiology of sleep and sleep and circadian disorders. He has written over 400 publications in scientific journals and books and authored a number of educational products for the general public.As a Sleep Medicine clinician, he is internationally recognized as an expert in obstructive sleep apnea and other sleep related breathing disorders. His patient care philosophy emphasizes listening to the patient and with their assistance delivering compassionate, evidence-based care. Dr. Quan is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Obstructive Sleep Apnea, Restless Legs Syndrome, COVID-19, and Excessive Daytime Sleepiness.

Geoffrey Gilmartin is a Pulmonary Medicine provider in Boston, Massachusetts. Dr. Gilmartin is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Cerebral Hypoxia, Eosinophilic Asthma, Chronic Eosinophilic Pneumonia, and Simple Pulmonary Eosinophilia.

Dr. George R. Washko, Jr. is a physician at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.He received his medical degree from Georgetown University School of Medicine. He then completed a residency in internal medicine at Beth Israel Deaconess Medical Center, followed by a fellowship in pulmonary disease at BWH. He is board certified in critical care medicine and pulmonary disease.Dr. Washko is a National Institutes of Health-funded investigator in chronic obstructive pulmonary disease (COPD), specifically focusing his work in imaging and quantitative image analysis. As the regional principal investigator on the National Heart, Lung, and Blood Institute’s COPD clinical research network, he is researching therapies for the prevention and treatment of COPD. He has written over 140 peer-reviewed publications, is the recipient of the Parker B. Francis fellowship and is a member of the American Society of Clinical Investigation. Dr. Washko is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Acute Interstitial Pneumonia, and Interstitial Lung Disease.

Dr. Aaron B. Waxman is the director of the Pulmonary Vascular Disease Program at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School.After receiving his medical degree from Yale University School of Medicine, Dr. Waxman completed a residency in internal medicine at Yale New Haven Hospital. He then completed two fellowships: the first at Howard Hughes Medical Institute, and the second in pulmonary and critical care at Yale New Haven Hospital. He is board certified in critical care medicine, internal medicine and pulmonary disease.Dr. Waxman’s clinical interests include pulmonary arterial hypertension (PAH), right heart failure, thromboembolic disease and pulmonary vascular disease. His research focuses on the inflammatory mechanisms of pulmonary vascular remodeling that lead to right heart failure. His research into the regulation of cell death proteins by IL-6 cytokines in mice led to the discovery of a relationship between dyspnea and mitochondrial dysfunction, and resulted in additional clinical studies examining the abnormalities of inflammatory mediators and oxygen extraction in patients with PAH. He has authored over 110 peer-reviewed publications and has received funding from the National Institutes of Health and the National Heart, Lung, and Blood Institute. Dr. Waxman is rated as an Advanced provider by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Interstitial Lung Disease, Lung Transplant, and Thrombectomy.